Search results
Q1 2024 Lisata Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 15 hours agoCertepetide spelled CERTEPETIDE is the official international non-proprietary name or INN United States Adopted name or USA and Australia's ...
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 11 hours ago(NASDAQ:NTLA) Q1 2024 Earnings Call Transcript May 9, 2024 Intellia Therapeutics, Inc. isn’t one of...
7 Massively Undervalued Penny Stocks to Buy for 7-Bagger Returns
InvestorPlace· 18 hours agoMy view is that expansionary monetary policy in the second half of 2024 is likely to be a major...
AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 days agoFrom a technology development perspective, our TCE platform is now nearly complete. In addition to...
With the Help of AI, Randy Travis Has Released His First Song Following His 2013 Stroke
Biography via Yahoo News· 4 days agoGrammy-winning musician Randy Travis repopularized the traditional sound of country music. Read...
Rakuten Medical Announces Poster Presentation and Booth Exhibition at ASCO 2024 Annual Meeting
FOX 4 Kansas City· 1 day agoSAN DIEGO, May 9, 2024 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy based on its
Pharma and Medical Startups on the Hook to Attract Strong Counsel
Bloomberg Law· 5 days agoTargeting legal counsel early in the process better positions companies to manage risk. Development of an invention—such as a new drug, method of treatment, medical device ...
Delcath Systems to Host First Quarter 2024 Earnings Call
CW39 NewsFix· 4 days agoDelcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call ...
Progress Toward a New GAD Treatment Paradigm
FierceBiotech· 5 days agoOn May 4, MindMed presented results from our Phase 2b clinical trial evaluating MM120, our proprietary, pharmaceutically optimized form of lysergide...
Citigroup Recommends 3 Stocks to Buy — Including One With 77% Upside Potential
TipRanks via Yahoo Finance· 4 days agoAfter a rocky month of April, investor sentiment has improved somewhat. At least in part, this can...
